Willekens R, Puig-Asensio M, Suanzes P, Fernandez-Hidalgo N, et al. Empirical use of beta-lactam/beta-lactamase inhibitor combinations does not
increase mortality compared with cloxacillin and cefazolin in
methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted
cohort study. J Antimicrob Chemother 2022 May 12. pii: 6584695. doi: 10.1093.
PMID: 35552420